PAEGF yields 200000.00% · JNJ yields 2.13%● Live data
📍 PAEGF pulled ahead of the other in Year 1
Combined, PAEGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PAEGF + JNJ for your $10,000?
Peace Arch Entertainment Group Inc. produces, acquires, and distributes feature films, television, and home entertainment content worldwide. It operates in three segments: Motion Picture, Television, and Home Entertainment. The Motion Picture segment produces feature films, which are intended for DVD or television premieres, as well as for worldwide theatrical release; licenses distribution rights of productions to sub-distributors; and distributes catalogues. The Television segment licenses television films, series of episodes, documentaries, and other programming to broadcasters, cable and satellite television providers, and home entertainment distributors. It also provides made-for-television movies and mini-series. The Home Entertainment segment distributes DVDs and ancillary merchandise to retailers in Canada and the United States. This segment also distributes sell-through and rental films of various genres, such as children's and family, special interest, and live action feature films. The company was formerly known as Vidatron Entertainment Group Inc. and changed its name to Peace Arch Entertainment Group Inc. in July 1999. Peace Arch Entertainment Group Inc. was founded in 1986 and is based in Toronto, Canada.
Full PAEGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.